EN
HI
Summary
As of 26 Aug, 2026, Glaxosmithkline Pharmaceuticals stock price is ₹2963.4. During the trading session, the stock has moved between an intraday low of ₹2917.60 and an intraday high of ₹3010.00. Over the last 52 weeks, Glaxosmithkline Pharmaceuticals has traded between ₹2088.10 and ₹3054.90.
The stock has recorded a trading volume of 1,74,436 shares, with a market capitalization of ₹169406034. Its Average Traded Price (ATP) is ₹2951.80, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2963.40.
Glaxosmithkline Pharmaceuticals has an upper circuit limit of ₹3518.00 and a lower circuit limit of ₹2345.40. The total value traded stands at ₹51.49 CR, and the delivery percentage for the day is 47.84%.
The stock is currently traded with a market lot size of 1. Glaxosmithkline Pharmaceuticals also offers a dividend yield of 1.95%.
Glaxosmithkline Pharmaceuticals share price chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
1.74 L
Market Cap
50201.78 CR
LTQ@LTP
2@2963.40
ATP
2951.8
Var Margin
15.65 %
Circuit Range
2345.4-3518
Delivery %
47.84 %
Value
51.49 CR
ASM/GSM
No
Market Lot
1
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
46.48
P/B Ratio
19.7
Div. Yield
1.95
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2917.67
Resistance
First Resistance
2969.94
Second Resistance
3008.17
Third Resistance
3060.44
Support
First Support
2879.44
Second Support
2827.17
Third Support
2788.94
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 2953.8 | 2963.4 | 1.08% | 3010 | 2917.6 |
| Mon Aug 24 2026 | 2875.1 | 2931.69 | 1.02% | 2955.89 | 2865.39 |
| Fri Aug 21 2026 | 2985 | 2902.19 | -3.25% | 2989.39 | 2880 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper Publication
GlaxoSmithKline Pharmaceuticals will hold a postal ballot for the re-appointment of Mr. Bhushan Akshikar as Managing Director. The voting period is from August 14 to September 13, 2026, with results by September 15, 2026.
Aug 14 2026 16:37:33
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
GlaxoSmithKline Pharmaceuticals seeks shareholder approval for the re-appointment of MD Bhushan Akshikar for a two-year term starting December 2026, with a basic salary up to ₹2.4 crores/month. Also proposes to appoint Ms. Karine J F Natland as a Non-Executive Director, with e-voting from August 14 to September 13, 2026.
Aug 13 2026 13:02:01
Read More
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Biocon Ltd.
417.20
7.80 (1.91%)
Aster DM Quality Care Ltd.
765.25
14.35 (1.91%)
Glenmark Pharmaceuticals Ltd.
2400.00
9.30 (0.39%)
Alkem Laboratories Ltd.
5368.00
18.00 (0.34%)
Abbott India Ltd.
26415.00
-5.00 (0.02%)
Anthem Biosciences Ltd.
874.70
-8.65 (0.98%)
Ipca Laboratories Ltd.
1928.50
8.10 (0.42%)
Gland Pharma Ltd.
2824.60
23.00 (0.82%)
Ajanta Pharma Ltd.
3554.90
-25.00 (0.70%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2963.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 46.48. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 19.7. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 50201.78 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3054.90 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
